Skip to content

Drug interactions

Atogepant + Doxorubicin

Severity: Minor

Atogepant and Doxorubicin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Doxorubicin is described as a CYP3A4 inhibitor, but it has little clinically meaningful CYP3A4 inhibition, so a real rise in atogepant levels is unlikely. The interaction is largely theoretical.

What this interaction means in plain words

Atogepant and Doxorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Doxorubicin belongs to Oncology.

Evidence level: Low

Why it happens

Theoretical weak CYP3A4 inhibition by doxorubicin; not an established effect.

What to do

No dose change is needed; monitor for atogepant adverse effects such as nausea, constipation or somnolence.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Doxorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Doxorubicin?

MediHelp rates the interaction as minor. Atogepant and Doxorubicin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Doxorubicin is described as a CYP3A4 inhibitor, but it has little clinically meaningful CYP3A4 inhibition, so a real rise in atogepant levels is unlikely. The interaction is largely theoretical.

How serious is the interaction between Atogepant and Doxorubicin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; monitor for atogepant adverse effects such as nausea, constipation or somnolence.

What other medicines interact with Doxorubicin?

MediHelp also lists interactions of Doxorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cobicistat. The full list is on the Doxorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in